• Oct 26, 2026

  $305.78-0.38%

  CI closed down 0.38%, a smaller decline than its comparable companies. Comparable Hospital & Medical Service Plans companies fell 2.00% on average, with all 5 of 5 declining [1]. The move came alongside a sector-wide decline, though CI fell by less than the cohort average [1].

  • 1Peer group

• Oct 23, 2026

  $306.95-2.83%

  Comparable Hospital & Medical Service Plans companies fell 1.50% on average, with 4 of 5 lower, so CI's decline came alongside a weak group [2]. CI fell more than that average. Seeking Alpha reported that CVS Caremark, Express Scripts and Optum Rx were targeted in a House investigation [1].

  • 1Seeking Alpha
  • 2Peer group

• Oct 22, 2026

  $315.88+3.78%

  CI rose 3.78%, while comparable Hospital & Medical Service Plans companies rose 1.13% on average, with 4 of 5 higher [1]. CI's gain was larger than the cohort average [1].

  • 1Peer group

• Oct 21, 2026

  $304.37-0.73%

  Comparable Hospital & Medical Service Plans companies fell 1.07% on average, with all 5 lower [1]. The stock's 0.73% decline came alongside that group-wide weakness [1].

  • 1Peer group

• Oct 20, 2026

  $306.60+2.71%

  Comparable Hospital & Medical Service Plans companies rose 3.21% on average, with all 5 of 5 higher [1]. CI's gain of 2.71% came alongside that sector-wide strength and was slightly smaller than the cohort average [1].

  • 1Peer group

• Oct 19, 2026

  $298.50-1.26%

• Oct 16, 2026

  $302.30+1.17%

  CI rose 1.17% while comparable Hospital & Medical Service Plans companies fell 2.01% on average, with all 5 of 5 declining [1]. The move was not shared by the cohort, as CI gained while every comparable company fell [1].

  • 1Peer group

Closing prices for CI. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.